GEODE CAPITAL MANAGEMENT, LLC - CONATUS PHARMACEUTICALS INC ownership

CONATUS PHARMACEUTICALS INC's ticker is CNAT and the CUSIP is 20600T108. A total of 36 filers reported holding CONATUS PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of CONATUS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2020$74,000
-64.8%
239,083
-54.8%
0.00%
Q4 2019$210,000
+180.0%
528,652
+121.1%
0.00%
Q3 2019$75,000
+21.0%
239,0830.0%0.00%
Q2 2019$62,000
-76.0%
239,0830.0%0.00%
Q1 2019$258,000
-64.2%
239,083
-42.6%
0.00%
Q4 2018$720,000
-28.9%
416,692
+138.8%
0.00%
Q3 2018$1,012,000
+35.8%
174,519
+0.2%
0.00%
Q2 2018$745,000
-63.6%
174,179
-50.1%
0.00%
-100.0%
Q1 2018$2,047,000
+3.2%
348,765
-18.8%
0.00%0.0%
Q4 2017$1,983,000
+6.2%
429,556
+26.2%
0.00%0.0%
Q3 2017$1,868,000
+34.4%
340,377
+41.0%
0.00%0.0%
Q2 2017$1,390,000
+129.8%
241,348
+129.9%
0.00%
Q1 2017$605,000
+33.0%
104,972
+21.4%
0.00%
Q4 2016$455,000
+199.3%
86,460
+13.0%
0.00%
Q3 2016$152,000
-3.2%
76,488
+0.1%
0.00%
Q2 2016$157,000
-3.7%
76,4340.0%0.00%
Q1 2016$163,000
-25.9%
76,434
-0.1%
0.00%
Q4 2015$220,000
-35.1%
76,488
+0.1%
0.00%
Q3 2015$339,000
-13.5%
76,380
+0.1%
0.00%
Q2 2015$392,000
+65.4%
76,305
+128.6%
0.00%
Q1 2015$237,000
+6.3%
33,383
+4.5%
0.00%
Q4 2014$223,000
+14.9%
31,931
+0.5%
0.00%
Q3 2014$194,000
-32.9%
31,769
-0.0%
0.00%
Q2 2014$289,000
+1.8%
31,783
-9.1%
0.00%
Q1 2014$284,000
+44.9%
34,969
+14.6%
0.00%
Q4 2013$196,000
-36.2%
30,5170.0%0.00%
Q3 2013$307,00030,5170.00%
Other shareholders
CONATUS PHARMACEUTICALS INC shareholders Q4 2019
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 2,464,807$14,468,0005.57%
COURAGE CAPITAL MANAGEMENT LLC 192,486$1,130,0000.86%
ESSEX INVESTMENT MANAGEMENT CO LLC 90,455$531,0000.07%
Alambic Investment Management, L.P. 86,204$506,0000.07%
Kalos Management, Inc. 30,000$164,0000.05%
Dynamic Technology Lab Private Ltd 32,394$190,0000.03%
ELLINGTON MANAGEMENT GROUP LLC 60,600$356,0000.03%
PRELUDE CAPITAL MANAGEMENT, LLC 55,008$323,0000.02%
REILLY FINANCIAL ADVISORS, LLC 22,011$129,0000.02%
ACADIAN ASSET MANAGEMENT LLC 580,972$3,411,0000.02%
View complete list of CONATUS PHARMACEUTICALS INC shareholders